Human leishmaniases: epidemiology and public health aspects.
about
Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish InfectionLeishmaniasis in Uganda: historical account and a review of the literatureTelehealth: a perspective approach for visceral leishmaniasis (kala-azar) control in India.Leishmaniasis-HIV coinfection: current challengesDifferential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapyIn silico sequence analysis, homology modeling and function annotation of leishmanolysin from Leishmania donovani.Visceral Leishmania as Unusual Cause of Splenic Peliosis in the United States.WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled studyCryptic Leishmania infantum infection in Italian HIV infected patients.Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India.Entomological study of sand flies (Diptera: Psychodidae: Phlebotominae) in Asalouyeh, the heartland of an Iranian petrochemical industry.Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasisSynthesis and antileishmanial activities of novel 3-substituted quinolines.Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.Atypical systemic leishmaniasis to be considered in the differential of patients presenting with depressed immunityAn outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani.Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update.Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis.Leishmania and human immunodeficiency virus coinfection: the first 10 yearsCharacterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both In Vitro and In VivoRisk factors for kala-azar in Bangladesh.Visceral leishmaniasis: A case reportNanospheres encapsulating anti-leishmanial drugs for their specific macrophage targeting, reduced toxicity, and deliberate intracellular release.Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patientsLive attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.Patients' associations and the control of leishmaniasis in Peru.Differential Role of Leptin as an Immunomodulator in Controlling Visceral Leishmaniasis in Normal and Leptin-Deficient Mice.Effect of human urine on cell cycle and infectivity of Leismania species promastigotes in vitro.Cutaneous Leishmaniasis in Saudi Arabia: A Comprehensive Overview.Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis.Drug resistance in leishmaniasis.Internal and surface-localized major surface proteases of Leishmania spp. and their differential release from promastigotes.Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from IndiaMolecular cloning, expression and enzymatic assay of pteridine reductase 1 from Iranian lizard Leishmania.Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice.
P2860
Q26739973-D64F50AF-BE03-48C0-BAD0-1503C9268DC9Q26830527-AF32293F-CCC2-4BEB-8AF1-9512A5CD0208Q27687817-678BC6FA-8408-4AF7-92DB-F0DC502AA227Q28078359-5F753E8F-4CF5-4507-AFB6-17CE12FD2135Q28343709-52796864-02C2-49C2-98BF-5B597FA658DFQ30395539-6C0C0179-4980-414B-986E-11586DB17098Q33424284-1AAD6FE1-D260-4598-BCAE-5335122C276DQ33438898-0070BA6F-6803-474D-A67B-CFC4A79F91BEQ33517885-7C77E8BA-29BB-4A79-8424-94ACC63BFD7AQ33578783-ACB769CF-A800-428D-B8F2-4EB017718890Q33628774-476011FB-3109-478D-A900-31E3A5E8BE3FQ33796005-237AD7EC-E96F-4223-9FF0-39948F611537Q33857721-B580A3A9-5B88-42E7-8081-86AB6C755E75Q34277331-D85A499B-D28C-4EBC-8DC9-89E13AF37A25Q34396122-FAAC1B8B-EB5B-4016-91BD-CCA7E953BF2BQ34552767-1A8D26EA-2069-4C9B-B24F-5A420B623F20Q34700686-3A497554-A74A-41D6-9010-F30E6C9316BBQ35089895-EBBECFF5-AC6F-43AA-9BAD-F104B64ABBBFQ35374078-8A59E9AA-774D-4F4F-9B7D-B2EDCE436080Q35548955-B00227F3-225B-4EA8-A089-5F950A9D2651Q35758135-6EABCCD2-63D5-444C-97AC-8F3F3F4419D5Q35873114-F4A34F81-DB96-496C-AE7F-C60A4CB020C9Q36147673-FA3F51A6-103A-45C0-B84E-705FDA60C01FQ36378915-00998359-51D5-4DA2-A78A-EE7B6DC56ED1Q36520830-8B9B2193-B8ED-41CC-A025-58D39DECC98EQ36625975-E8068F22-63C0-4B0E-8EEF-E3B221E870AEQ36795405-9AAC33D5-6F45-40C6-839F-2452D374A2F9Q37094405-8AA008F1-59C8-4B6C-BD2A-5AB007C9C680Q38597688-97DBF25D-0C42-4FA6-9AC4-6ED833DFFAEDQ40083949-4258DD8A-FEB7-4429-AD43-ED3459E7E42FQ40582686-2B030F99-7048-4130-A2BD-38F00298DBCFQ41271991-1CE751D1-CC7F-4EBE-A4E4-A77B982DE3FFQ42018150-39966C84-0D6A-4D9D-950C-86F8C00B433BQ42431874-01C32F9E-723A-4CD9-AB25-8A28864CF1F4Q42732972-0D2E8F6C-582A-40A0-AA88-6D391309520FQ47098436-55B2BAEC-EBAC-42EE-A191-8E0597A1538C
P2860
Human leishmaniases: epidemiology and public health aspects.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Human leishmaniases: epidemiology and public health aspects.
@en
type
label
Human leishmaniases: epidemiology and public health aspects.
@en
prefLabel
Human leishmaniases: epidemiology and public health aspects.
@en
P1476
Human leishmaniases: epidemiology and public health aspects.
@en
P2093
P304
P577
1992-01-01T00:00:00Z